Skip to main content
Signal8

LALANDE KEVIN M.

SEC insider (Form 3/4/5 filer). CIK 0001587800. Director at LUMOS PHARMA, INC. ((LUMO)) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 12, 2024. Located in AUSTIN, TX.

Companies LALANDE KEVIN M. has filed insider reports for

  • LUMOS PHARMA, INC. ((LUMO)): Director
  • Molecular Templates, Inc. (MTEM): Director, 10% Owner
LALANDE KEVIN M. profile photo

LALANDE KEVIN M.

CIK: 0001587800

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LUMOS PHARMA, INC. logo
(LUMO)

LUMOS PHARMA, INC.

Director
Molecular Templates, Inc. logo
MTEM

Molecular Templates, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • LUMOS PHARMA, INC. logo
    (LUMO)

    LUMOS PHARMA, INC.

    Dec 12, 2024
    Disposition
    Direct
    1.1K shares-
  • LUMOS PHARMA, INC. logo
    (LUMO)

    LUMOS PHARMA, INC.

    Dec 12, 2024
    Disposition
    Indirect
    730.4K shares-
  • Molecular Templates, Inc. logo
    MTEM

    Molecular Templates, Inc.

    Sep 27, 2024
    Award

    Stock Option (right to buy)

    Direct
    1K shares-

1-3 of 3